Following US approval in May this year, South Korea’s Samsung Bioepis and US biotech Biogen have now won approval from the ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today. The company’s shares closed last ...
Worldcrunch on MSN18m
Leqembi, Is This New Drug The Turning Point In Curing Alzheimer’s?That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...
IQVIA Holdings (IQV) is down more than -2% after Mizuho Securities cut its price target on the stock to $247 from $277. Biogen (BIIB) is down more than -1% after Needham downgraded the stock to hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback